These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 7220138
1. Renal function in rats with unilateral proteinuria produced by renal perfusion with aminonucleoside. Chandra M, Hoyer JR, Lewy JE. Pediatr Res; 1981 Apr; 15(4 Pt 1):340-4. PubMed ID: 7220138 [Abstract] [Full Text] [Related]
2. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside. Hoyer JR, Mauer SM, Michael AF. J Lab Clin Med; 1975 May; 85(5):756-68. PubMed ID: 1091713 [Abstract] [Full Text] [Related]
3. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats. Couser WG, Jermanovich NB, Belok S, Stilmant MM, Hoyer JR. J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884 [Abstract] [Full Text] [Related]
4. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside. Schwartz MM, Sharon Z, Pauli BU, Lewis EJ. Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977 [Abstract] [Full Text] [Related]
5. Unilateral renal disease in the rat. II. Glomerular mesangial uptake of colloidal carbon in unilateral aminonucleoside nephrosis and nephrotoxic serum nephritis. Hoyer JR, Elema JD, Vernier RL. Lab Invest; 1976 Mar; 34(3):250-5. PubMed ID: 1082531 [Abstract] [Full Text] [Related]
6. Experimental focal segmental glomerulosclerosis: correlation with protein excretion, glomerular filtration rate, and renal plasma flow. Chandra M, Susin M, Teichberg S, McVicar M. Pediatr Res; 1984 Nov; 18(11):1195-201. PubMed ID: 6514447 [Abstract] [Full Text] [Related]
7. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention. Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Chávez MT, Calleja C, Tapia E, del Carmen Uribe M, Romero L, Peña JC. Rev Invest Clin; 1990 Nov; 42(1):29-38. PubMed ID: 2236972 [Abstract] [Full Text] [Related]
8. Beneficial effects of orosomucoid on the glomerular barrier in puromycin aminonucleoside-induced nephrosis. Hjalmarsson C, Lidell ME, Haraldsson B. Nephrol Dial Transplant; 2006 May; 21(5):1223-30. PubMed ID: 16410268 [Abstract] [Full Text] [Related]
9. Effects of aminonucleoside, daunomycin, and adriamycin on carbon oxidation by glomeruli. Kaplan BS, Renaud L, Drummond KN. Lab Invest; 1976 Feb; 34(2):174-8. PubMed ID: 1249918 [Abstract] [Full Text] [Related]
10. Studies on the control of sodium excretion in experimental uremia. Schultze RG, Shapiro HS, Bricker NS. J Clin Invest; 1969 May; 48(5):869-77. PubMed ID: 5780197 [Abstract] [Full Text] [Related]
11. Effect of TGF-beta1 antisense oligodeoxynucleotide on renal function in chronic renal failure rats. Hiong LC, Voon KL, Abdullah NA, Sattar MA, Rahman NA, Khan AH, Johns EJ. Acta Pharmacol Sin; 2008 Apr; 29(4):451-7. PubMed ID: 18358091 [Abstract] [Full Text] [Related]
12. Dependence of saline-induced natriuresis upon exposure of the kidney to the physical effects of extracellular fluid volume expansion. Fitzgibbons JP, Gennari FJ, Garfinkel HB, Cortell S. J Clin Invest; 1974 Dec; 54(6):1428-36. PubMed ID: 4436441 [Abstract] [Full Text] [Related]
13. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats. Olson JL, Rennke HG, Venkatachalam MA. Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051 [Abstract] [Full Text] [Related]
14. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome. Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M. Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272 [Abstract] [Full Text] [Related]
15. Role for intrarenal mechanisms in the impaired salt excretion of experimental nephrotic syndrome. Ichikawa I, Rennke HG, Hoyer JR, Badr KF, Schor N, Troy JL, Lechene CP, Brenner BM. J Clin Invest; 1983 Jan; 71(1):91-103. PubMed ID: 6848563 [Abstract] [Full Text] [Related]
16. Determinants of glomerular localization of subepithelial immune deposits: effects of altered antigen to antibody ratio, steroids, vasoactive amine antagonists, and aminonucleoside of puromycin on passive Heymann nephritis in rats. Salant DJ, Belok S, Stilmant MM, Darby C, Couser WG. Lab Invest; 1979 Jul; 41(1):89-99. PubMed ID: 376941 [Abstract] [Full Text] [Related]
17. Demonstraton of a role of physical factors as determinants of the natriuretic response to volume expansion. Martino JA, Earley LE. J Clin Invest; 1967 Dec; 46(12):1963-78. PubMed ID: 6074001 [Abstract] [Full Text] [Related]
18. Severe proteinuria without impairment of sodium and volume excretion after puromycin aminonucleoside administration in rats. Palluk R, Veress AT, Sonnenberg H. Pharmacology; 1989 Dec; 38(4):214-25. PubMed ID: 2526952 [Abstract] [Full Text] [Related]
19. Combined light and electron-microscope morphometric studies of acute puromycin aminonucleoside nephropathy in rats. Pinto JA, Brewer DB. J Pathol; 1975 Jul; 116(3):149-64. PubMed ID: 1104792 [Abstract] [Full Text] [Related]
20. Micropuncture study of fluid transfer in aminonucleoside nephrosis in the rat. Lewy JE. Pediatr Res; 1976 Jan; 10(1):30-4. PubMed ID: 1246462 [Abstract] [Full Text] [Related] Page: [Next] [New Search]